GENOVA Inc. (9341) AI Stock Analysis

• Market Cap: ¥12.66B
• Dividend Yield: 4.22%
• Average Volume (3M): 97.31K
• Price to Earnings (P/E): 8.9
• Beta (1Y): 1.02
• Revenue Growth: 15.23%
• EPS Growth: -17.97%
• Country: JP
• Employees: 352
• Sector: Healthcare
• Sector Strength: 37
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 18.75
• Shares Outstanding: 17,810,600
• 10 Day Avg. Volume: 95,760
• 30 Day Avg. Volume: 97,310
• PEG Ratio: -0.36
• Price to Book (P/B): 1.77
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥783.00
• Price Target Upside: 10.13% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 69 Neutral
• Price Target: ¥783.00 ▲(10.13%Upside)

GENOVA Inc.'s overall stock score is driven primarily by its strong financial performance, characterized by solid revenue growth and a healthy balance sheet. However, weak technical indicators and a bearish market momentum are significant risks, offsetting some of the financial strengths. The stock valuation is appealing due to a low P/E ratio and a high dividend yield, but technical challenges dominate the short-term outlook.

GENOVA Inc. Business Overview & Revenue Model

Company Description

GENOVA Inc. (9341) is a diversified company operating primarily in the technology and manufacturing sectors. The company specializes in the development and production of advanced materials and components, catering to industries such as aerospace, automotive, and electronics. GENOVA Inc. is known for its innovation in creating high-performance products that enhance efficiency and sustainability across various applications.

How the Company Makes Money

GENOVA Inc. generates revenue through the sale of its advanced materials and components to major industries like aerospace, automotive, and electronics. The company's key revenue streams include long-term contracts with OEMs (Original Equipment Manufacturers), licensing of proprietary technology, and strategic partnerships with other firms for research and development. Additionally, GENOVA Inc. invests in joint ventures to further expand its market presence and leverage new technologies. The company's earnings are significantly influenced by its ability to innovate and maintain strong relationships with industry leaders, ensuring a steady demand for its products.

GENOVA Inc. Financial Statement Overview

Summary

GENOVA Inc. demonstrates strong financial health with excellent revenue growth and efficient cost management. The balance sheet is robust with low leverage, enhancing financial stability. Despite strong cash flows, the recent slowdown in Free Cash Flow growth and slight decline in Net Profit Margin suggest areas for monitoring.

Income Statement

GENOVA Inc. shows strong revenue growth, with a consistent increase in Total Revenue over multiple years. The Gross Profit Margin is robust, reflecting efficient cost management. However, the Net Profit Margin has slightly decreased in the last year, indicating some pressure on profitability despite the revenue growth.

Balance Sheet

The company maintains a healthy balance sheet with a low Debt-to-Equity Ratio, indicating low leverage. The high Equity Ratio signifies a strong equity foundation relative to total assets. Return on Equity is solid, demonstrating efficient use of equity to generate profits.

Cash Flow

Operating Cash Flow remains positive and strong, although it has declined in the most recent period. Free Cash Flow is also substantial, but its growth has slowed down. The Operating Cash Flow to Net Income Ratio is stable, supporting the company’s ability to generate cash from its operations.

Breakdown	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	10.01B	8.68B	6.51B	4.80B	3.77B
Gross Profit	7.38B	6.55B	4.79B	3.50B	2.63B
EBITDA	2.10B	2.37B	1.77B	1.10B	821.56M
Net Income	1.41B	1.73B	1.26B	686.27M	629.35M
Balance Sheet
Total Assets	8.53B	8.20B	5.41B	2.82B	1.87B
Cash, Cash Equivalents and Short-Term Investments	5.87B	5.97B	3.86B	1.65B	1.17B
Total Debt	20.84M	377.78M	28.25M	163.50M	133.42M
Total Liabilities	1.53B	2.16B	1.37B	1.33B	1.10B
Stockholders Equity	7.00B	6.04B	4.04B	1.49B	768.34M
Cash Flow
Free Cash Flow	1.06B	1.77B	1.11B	508.47M	1.04B
Operating Cash Flow	1.19B	1.82B	1.20B	623.77M	1.06B
Investing Cash Flow	-275.93M	-94.24M	-113.45M	-179.06M	-68.18M
Financing Cash Flow	-1.01B	376.82M	1.13B	59.88M	-75.09M

GENOVA Inc. Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 711.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9341, the sentiment is Neutral. The current price of 711 is above the 20-day moving average (MA) of 709.00, below the 50-day MA of 719.44, and below the 200-day MA of 1142.55, indicating a bearish trend. The MACD of -9.52 indicates Negative momentum. The RSI at 45.17 is Neutral, neither overbought nor oversold. The STOCH value of 67.26 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:9341.

GENOVA Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6095	81 Outperform	¥16.77B	9.68		0.64%	-12.13%	291.07%
4320	73 Outperform	¥11.62B	23.59		2.58%	9.21%	-20.04%
3939	72 Outperform	¥20.87B	21.15		1.45%	17.20%	20.25%
9341	69 Neutral	¥12.66B	8.91		4.22%	15.23%	-17.97%
Sector *	52 Neutral	$7.60B	0.11	-62.95%	2.07%	16.16%	0.31%
3628	50 Neutral	¥7.56B	―		―	16.49%	-483.70%
3902	43 Neutral	¥20.16B	4,465.71		1.26%	-7.98%	-181.00%

GENOVA Inc. Corporate Events

GENOVA Inc. Announces Executive Officer Appointments

GENOVA Inc. announced new appointments for its Directors and Executive Officers, effective June 25, 2025, following a resolution at an extraordinary Board of Directors meeting. These changes are expected to impact the company’s operations across various departments, potentially influencing its strategic direction and stakeholder relations.

The most recent analyst rating on (JP:9341) stock is a Buy with a Yen56.00 price target. To see the full list of analyst forecasts on GENOVA Inc. stock, see the JP:9341 Stock Forecast page.

GENOVA Inc. Proposes Amendments to Articles of Incorporation

GENOVA Inc. announced proposed amendments to its Articles of Incorporation, to be discussed at the upcoming General Meeting of Shareholders. These amendments aim to incorporate business activities related to secondhand goods and clarify operations in the dental and medical equipment sectors, reflecting the company’s strategic focus on expanding its service offerings and operational scope.

The most recent analyst rating on (JP:9341) stock is a Buy with a Yen58.00 price target. To see the full list of analyst forecasts on GENOVA Inc. stock, see the JP:9341 Stock Forecast page.

GENOVA Inc. Finalizes Stock Acquisition Rights Terms

GENOVA Inc. has finalized the terms for issuing paid stock acquisition rights to its executive officers, as resolved by the Board of Directors on May 1, 2025. This issuance involves 3,570 stock acquisition rights, allowing for the exercise of 357,000 shares of common stock, which could impact the company’s equity structure and provide incentives for its executives.

The most recent analyst rating on (JP:9341) stock is a Buy with a Yen58.00 price target. To see the full list of analyst forecasts on GENOVA Inc. stock, see the JP:9341 Stock Forecast page.

GENOVA Inc. Reports Increased Sales but Declining Profits for FY 2025

GENOVA Inc. reported its consolidated financial results for the fiscal year ended March 31, 2025, showing a 15.2% increase in net sales to ¥10,006 million. However, the company experienced a decline in operating and ordinary profits, with decreases of 12.0% and 12.6% respectively, and a significant drop in profit attributable to owners of the parent by 18.1% to ¥1,413 million. Despite the profit decline, GENOVA Inc. announced a year-end dividend of ¥30.00 per share, including a commemorative dividend for its 20th fiscal year, indicating a commitment to shareholder returns.

The most recent analyst rating on (JP:9341) stock is a Buy with a Yen58.00 price target. To see the full list of analyst forecasts on GENOVA Inc. stock, see the JP:9341 Stock Forecast page.

GENOVA Inc. Issues Stock Options to Boost Growth

GENOVA Inc. has announced the issuance of stock acquisition rights to its Executive Officers, aimed at enhancing motivation and morale to drive medium- to long-term growth in business performance and corporate value. The issuance is structured to align with performance targets, ensuring it contributes positively to corporate and shareholder value, while maintaining a reasonable dilution level for existing shareholders.